Phage therapy: concept to cure.
作者信息
Keen Eric C
机构信息
Department of Natural Sciences, Montgomery College Germantown, MD, USA.
出版信息
Front Microbiol. 2012 Jul 19;3:238. doi: 10.3389/fmicb.2012.00238. eCollection 2012.
Abstract
摘要
相似文献
1
Phage therapy: concept to cure.
Front Microbiol. 2012 Jul 19;3:238. doi: 10.3389/fmicb.2012.00238. eCollection 2012.
2
Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
Infez Med. 2020 Sep 1;28(3):322-331.
3
The forgotten tale of Brazilian phage therapy.
Lancet Infect Dis. 2020 May;20(5):e90-e101. doi: 10.1016/S1473-3099(20)30060-8. Epub 2020 Mar 23.
4
Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?
Antibiotics (Basel). 2019 Oct 11;8(4):182. doi: 10.3390/antibiotics8040182.
5
Phage therapy dosing: The problem(s) with multiplicity of infection (MOI).
Bacteriophage. 2016 Aug 11;6(3):e1220348. doi: 10.1080/21597081.2016.1220348. eCollection 2016 Jul-Sep.
6
Implementation of a targeted mastitis therapy concept using an on-farm rapid test: antimicrobial consumption, cure rates and compliance.
Vet Rec. 2020 Nov 14;187(10):401. doi: 10.1136/vr.105674. Epub 2020 Oct 6.
7
[A short history of phage therapy].
Med Mal Infect. 2008 Aug;38(8):415-20. doi: 10.1016/j.medmal.2008.06.016. Epub 2008 Aug 9.
8
Phage-Mediated Gene Therapy.
Curr Gene Ther. 2017;17(2):120-126. doi: 10.2174/1566523217666170510151940.
9
A CRISPR-Cas9-Based Toolkit for Fast and Precise In Vivo Genetic Engineering of Phages.
Viruses. 2018 May 4;10(5):241. doi: 10.3390/v10050241.
10
JD419, a Phage With a Unique Morphology and Broad Host Range.
Front Microbiol. 2021 Apr 22;12:602902. doi: 10.3389/fmicb.2021.602902. eCollection 2021.
引用本文的文献
1
Deep learning-guided structural analysis of a novel bacteriophage KPP105 against multidrug-resistant .
Comput Struct Biotechnol J. 2025 May 1;27:1827-1837. doi: 10.1016/j.csbj.2025.04.032. eCollection 2025.
2
Phage treatment of multidrug-resistant bacterial infections in humans, animals, and plants: The current status and future prospects.
Infect Med (Beijing). 2025 Feb 5;4(1):100168. doi: 10.1016/j.imj.2025.100168. eCollection 2025 Mar.
3
Therapeutic potential of a newly isolated bacteriophage against multi-drug resistant Enterococcus faecalis infections: in vitro and in vivo characterization.
BMC Microbiol. 2025 Feb 20;25(1):80. doi: 10.1186/s12866-025-03785-z.
4
Isolation and preliminary characterization of a novel bacteriophage vB_KquU_φKuK6 that infects the multidrug-resistant pathogen .
Front Microbiol. 2024 Oct 15;15:1472729. doi: 10.3389/fmicb.2024.1472729. eCollection 2024.
5
Invasions of Host-Associated Microbiome Networks.
Adv Ecol Res. 2017;57:201-281. doi: 10.1016/bs.aecr.2016.11.002.
6
Bacterial diseases in marine fish species: current trends and future prospects in disease management.
World J Microbiol Biotechnol. 2023 Sep 25;39(11):317. doi: 10.1007/s11274-023-03755-5.
7
The Lytic Activity of Bacteriophage ZCSE9 against and Its Synergistic Effects with Kanamycin.
Viruses. 2023 Mar 31;15(4):912. doi: 10.3390/v15040912.
8
Isolation of new phage PSKP16.
Iran J Microbiol. 2023 Feb;15(1):62-68. doi: 10.18502/ijm.v15i1.11919.
9
Characterization of Novel Phage PG14 and Its Antibiofilm Efficacy.
Microbiol Spectr. 2022 Dec 21;10(6):e0199422. doi: 10.1128/spectrum.01994-22. Epub 2022 Nov 14.
10
Chitosan-Based Microparticle Encapsulated Phage Cocktail in Hydrogel Matrix for the Management of Multidrug Resistant Chronic Wound Infection.
Turk J Pharm Sci. 2022 Apr 29;19(2):187-195. doi: 10.4274/tjps.galenos.2021.72547.
本文引用的文献
1
Comparison of culture and molecular identification of bacteria in chronic wounds.
Int J Mol Sci. 2012;13(3):2535-2550. doi: 10.3390/ijms13032535. Epub 2012 Feb 23.
2
Bug breakfast in the Bulletin: antimicrobial resistance: moving forward to the past.
N S W Public Health Bull. 2012 Jan-Feb;23(1-2):37. doi: 10.1071/NB11043.
3
Pathogen identification with laser-induced breakdown spectroscopy: the effect of bacterial and biofluid specimen contamination.
Appl Opt. 2012 Mar 1;51(7):B99-107. doi: 10.1364/AO.51.000B99.
4
Phage treatment of human infections.
Bacteriophage. 2011 Mar;1(2):66-85. doi: 10.4161/bact.1.2.15845.
5
Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.
Infect Immun. 2012 Jan;80(1):62-73. doi: 10.1128/IAI.05496-11. Epub 2011 Oct 17.
6
The next generation of bacteriophage therapy.
Curr Opin Microbiol. 2011 Oct;14(5):524-31. doi: 10.1016/j.mib.2011.07.028. Epub 2011 Aug 23.
7
Preserving the lifesaving power of antimicrobial agents.
JAMA. 2011 Mar 9;305(10):1027-8. doi: 10.1001/jama.2011.279. Epub 2011 Feb 22.
8
PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response.
Microb Biotechnol. 2008 May;1(3):247-57. doi: 10.1111/j.1751-7915.2008.00028.x.
9
Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
Trends Biotechnol. 2010 Dec;28(12):591-5. doi: 10.1016/j.tibtech.2010.08.001. Epub 2010 Aug 31.
10
Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial.
Vet Microbiol. 2010 Dec 15;146(3-4):309-13. doi: 10.1016/j.vetmic.2010.05.014. Epub 2010 May 12.
Zotero 插件